Melanoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Recruiting
  • Pancreatic Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
A Prospective Randomized and Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
Recruiting
  • Melanoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
N
The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (EDEN)
Suspended
  • Melanoma
  • Intervention Arm
  • Standard diet and exercise
  • Loma Linda, California
  • +1 more
2022-04-07
Apr 7, 2022
P
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
Recruiting
  • Oncology
  • +9 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +2 more
2022-04-07
Apr 7, 2022
C
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
Recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
2022-04-06
Apr 6, 2022
C
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
2022-04-06
Apr 6, 2022
H
Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma
Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
2022-04-07
Apr 7, 2022
N
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
Enrolling by invitation
  • Melanoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Harvesting Cells for Experimental Cancer Treatments
    Enrolling by invitation
    • Melanoma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      N
      Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
      Active, not recruiting
      • Prostate Cancer
      • +4 more
        • Bethesda, Maryland
          National Cancer Institute (NCI), 9000 Rockville Pike
        2022-04-07
        Apr 7, 2022
        N
        Retinoblastoma Biomarker Study
        Active, not recruiting
        • Retinoblastoma
        • +2 more
          • Bethesda, Maryland
            National Cancer Institute (NCI), 9000 Rockville Pike
          2022-04-07
          Apr 7, 2022
          N
          Collecting Solid Tumor Tissue to Identify New Treatments
          Completed
          • Gastrointestinal Cancer
          • +3 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            2022-04-07
            Apr 7, 2022
            N
            Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
            Recruiting
            • Xeroderma Pigmentosum
            • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              2022-04-07
              Apr 7, 2022
              M
              Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
              Active, not recruiting
              • Melanoma Stage Iv
              • +2 more
              • Albury, New South Wales, Australia
              • +9 more
              2022-04-06
              Apr 6, 2022
              R
              Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma - 2020
              Completed
              • Dysplastic Nevus
              • +3 more
              • Best Practice
              • +2 more
              • New Brunswick, New Jersey
                Rutgers Cancer Institute of New Jersey
              2022-04-05
              Apr 5, 2022
              I
              A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma - 2021
              Completed
              • Melanoma
              • London, United Kingdom
              • +1 more
              2022-04-06
              Apr 6, 2022
              N
              Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
              Recruiting
              • Advanced Malignant Solid Neoplasm
              • +49 more
              • Birmingham, Alabama
              • +1423 more
              2022-04-06
              Apr 6, 2022
              H
              A Study of HFB200301 in Adult Patients With Advanced Solid Tumors
              Recruiting
              • Gastric Cancer
              • +8 more
              • Los Angeles, California
              • +2 more
              2022-04-05
              Apr 5, 2022
              N
              A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
              Recruiting
              • Melanoma
              • Los Angeles, California
              • +3 more
              2022-03-29
              Mar 29, 2022
              N
              Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
              Recruiting
              • Pancreatic Cancer
              • +15 more
              • Grand Rapids, Michigan
              • +2 more
              2022-04-05
              Apr 5, 2022
              M
              Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma
              Active, not recruiting
              • Melanoma
              • Sydney, New South Wales, Australia
              • +2 more
              2022-04-04
              Apr 4, 2022
              S
              A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies - 2018
              Completed
              • Acute Myeloid Leukemia
              • +8 more
              • DSP-7888 Dosing Emulsion
              • Denver, Colorado
              • +7 more
              2022-04-04
              Apr 4, 2022
              H
              A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
              Recruiting
              • Neoplasms
              • +27 more
              • Culver City, California
              • +29 more
              2022-04-05
              Apr 5, 2022
              D
              DNX-2440 for Resectable Colorectal Liver Metastasis
              Recruiting
              • Liver Metastases
              • +10 more
              • DNX-2440
              • Tampa, Florida
                H. Lee Moffitt Cancer Center and Research Institute, Inc.
              2022-03-28
              Mar 28, 2022
              I
              QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
              Active, not recruiting
              • Non-Small Cell Lung Cancer
              • +12 more
              • N-803 + Pembrolizumab
              • +9 more
              • Anchorage, Alaska
              • +34 more
              2022-04-04
              Apr 4, 2022